Thermo Fisher Scientific Expands Oncomine Immuno-Oncology Assay Portfolio
Oncomine TCR Beta-SR Assay for next-generation sequencing enables site-specific interrogation for T-cell receptor applications CARLSBAD, Calif., June 28, 2018 /PRNewswire/ — Thermo Fisher Scientific today announced the launch of its Oncomine TCR Beta-SR Assay, a new next-generation sequencing (NGS) solution for immuno-oncology research designed to characterize T-cell clonality in the tumor microenvironment – a key approach... Read more